Feldschuh Jonathan Adam

CSO Jonathan Feldschuh buys 18,000 DXR shares, raising stake to 53,908; stock near 52-week lows amid unprofitable operations and -8.4% annual revenue decline.

Chief Scientific Officer Jonathan Feldschuh purchased 18,000 shares of Daxor Corp on 2025-12-09 at a $0.00 reported price, increasing his holdings by 50.1% to 53,908 shares post-transaction. The transaction occurs with DXR trading at $12.33, down 11.9% from its 52-week high of $14.00 and showing negative near-term momentum (-3.7% over 30 days). Fundamentally, the company faces significant headwinds: annual revenue declined 8.4% year-over-year, the latest quarterly revenue stands at $340,907.00, and net income was negative at -$4,183,669.00 over the most recent full fiscal year. Notably, Feldschuh's prior buy at this ticker on 2024-12-06 showed poor timing, with the stock declining 12.6% over both the 30-day and 90-day windows post-purchase—a pattern that recurred with the current acquisition entering a period of market weakness.

Chief Scientific Officer Feldschuh purchased 32,000 shares (818.8% increase to 35.9K shares) of unprofitable DXR on 2024-12-06

Jonathan Adam Feldschuh, the Chief Scientific Officer, acquired 32,000 shares of DAXOR CORP, increasing his holdings from 3,908 shares to 35.9K shares — an 818.8% increase in his position. This represents a substantial commitment by a key executive at a company with significant financial headwinds: the company reported a net income of $-4.2M, annual revenue decline of -8.4%, and a market cap of only $37.4M. The acquisition occurred at a transaction price of n/a (value reported as $0.00), which raises questions about the terms of the acquisition and warrants investigation into whether this was a grant, exercise, or other non-market transaction rather than an open-market purchase. Given the CSO's role in scientific direction and the company's unprofitable state, the substantial increase in insider ownership stake merits examination of the economic and structural circumstances surrounding the transaction.